BLSM Insider Buy: OrbiMed Advisors Spends $10M on Shares
A director of BlossomHill Therapeutics, Inc. (BLSM) put real money on the table this week. According to a Form 4 filing, OrbiMed Advisors LLC purchased 625,000 shares of BlossomHill on August 10, 2026, in an open-market transaction priced at $16.00 per share. The total outlay came to an even $10,000,000.00, funded directly by the insider … Read more